Abstract 5745: Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC von de Azevedo, Ricardo A., Turner, Broderick, Jayaprakash, Priyamvada, Bhanu, Krithikaa Rajkumar, Srinivasamani, Anupallavi, Morrow, Brittany, Winkler, Michelle, Hedge, Shweta Mahendra, Liu, Arthur, Slay, Ravaen, Curran, Michael A.

Volltext

Abstract 4213: Targeting the cMet inhibitors combined with anti-PD-1 therapy: Preclinical approach to turn the resistance into opportunities for overcoming tumor evasion von de Azevedo, Ricardo Alexandre, Cheng-En, Hsieh, Jayaprakash, Priyamvada, Bhanu, Krithikaa Rajkumar, Srinivasamani, Anupallavi, Morrow, Brittany, Winkler, Michelle, Hedge, Shweta Mahendra, Liu, Arthur, Curran, Michael A.

Volltext

Abstract 4183: Differential modulation of tumor versus T cell oxidative phosphorylation potentiates anti-tumor immunity von Bhanu, Krithikaa Rajkumar, Jayaprakash, Priyamvada, Rice, Meghan, Morrow, Brittany, Marszalek, Joseph R., Gay, Jason P., Vellano, Christopher P., Cowen, Benjamin R., Welsh, Dean J., Curran, Michael A.

Volltext

Biomechanical Regulation of Hematopoietic Stem Cells in the Developing Embryo von Horton, Paulina D., Dumbali, Sandeep P., Bhanu, Krithikaa Rajkumar, Diaz, Miguel F., Wenzel, Pamela L.

Volltext

592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer von Hsieh, Rodney Cheng-En, Krishnan, Sunil, Wu, Ren-Chin, Boda, Akash, Liu, Arthur, Winkler, Michelle, Hsu, Wen-Hao, Lin, Steven, Hung, Mien-Chie, Chan, Li-Chuan, Bhanu, Krithikaa, Srinivasamani, Anupallavi, Azevedo, Ricardo De, Chou, Yung-Chih, Depinho, Ronald, Gubin, Matthew, Vilar-Sanchez, Eduardo, Chen, Chao-Hsien, Slay, Ravaen, Jayaprakash, Priyamvada, Hegde, Shweta, Hartley, Genevieve, Lea, Spencer, Prasad, Rishika, Morrow, Brittany, Couillault, Coline, Steiner, Madeline, Wang, Chun-Chieh, Venkatesulu, Bhanu, Taniguchi, Cullen, Kim, Betty, Chen, Junjie, Rudqvist, Nils-Petter, Curran, Michael

Volltext

1154 High-potency synthetic STING agonists rewire myeloid subsets in the tumour microenvironment to dismantle immunosuppressive stroma in refractory pancreatic ductal adenocarcinom... von Boda, Akash, Ager, Casey, Rajapakshe, Kimal, Krithikaa, Rajkumar Bhanu, Spencer, Lea, Curran, Michael

Volltext

831 Targeting tumor oxidative metabolism to overcome hypoxia-induced immunotherapy resistance in prostate cancer von Jayaprakash, Priyamvada, Curran, Michael, Morrow, Brittany, Marszalek, Joseph, Krithikaa, Rajkumar Bhanu, Rice, Meghan, Gay, Jason, Vellano, Christopher, Cowen, Benjamin, Welsch, Dean

Volltext